Dabrafenib + Trametinib in Cancer Treatment - FOI Response Register

I would be grateful if you could please answer these questions relating to the usage of Dabrafenib + Trametinib in cancer treatment.

1. Over the previous 6 months, how many patients for the following diseases have been treated with a combination of Dabrafenib + Trametinib:

a) Metastatic Melanoma

b) Adjuvant Melanoma

b) BRAF mutated Lung Cancer

Please note these treatments are not currently delivered in Shetland. Cancer patients are managed by specialist at NHS Grampian.

If you have asked NHS Grampian for this information they will include residents of Shetland in their response.

If you have not yet asked NHS Grampian for this information their FOI contact points and publication scheme can be found at:

https://www.nhsgrampian.org/about-us/corporate-documents-and-commitments/freedom-of-information/